nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP4A11—Phenobarbital—epilepsy syndrome	0.0511	0.0833	CbGbCtD
Tretinoin—CYP2C18—Clobazam—epilepsy syndrome	0.0338	0.0552	CbGbCtD
Tretinoin—CYP2C18—Phenytoin—epilepsy syndrome	0.0251	0.041	CbGbCtD
Tretinoin—CYP2C18—Propofol—epilepsy syndrome	0.0234	0.0383	CbGbCtD
Tretinoin—CYP2C18—Phenobarbital—epilepsy syndrome	0.0224	0.0366	CbGbCtD
Tretinoin—CYP2C18—Diazepam—epilepsy syndrome	0.0212	0.0347	CbGbCtD
Tretinoin—CYP2C18—Valproic Acid—epilepsy syndrome	0.0167	0.0273	CbGbCtD
Tretinoin—CYP2A6—Amobarbital—epilepsy syndrome	0.0153	0.0249	CbGbCtD
Tretinoin—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0123	0.0201	CbGbCtD
Tretinoin—CYP2A6—Propofol—epilepsy syndrome	0.0114	0.0186	CbGbCtD
Tretinoin—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0111	0.0182	CbGbCtD
Tretinoin—CYP2A6—Phenobarbital—epilepsy syndrome	0.0109	0.0178	CbGbCtD
Tretinoin—CYP2B6—Clobazam—epilepsy syndrome	0.0107	0.0175	CbGbCtD
Tretinoin—CYP2C8—Trimethadione—epilepsy syndrome	0.00994	0.0162	CbGbCtD
Tretinoin—CYP1A1—Propofol—epilepsy syndrome	0.00974	0.0159	CbGbCtD
Tretinoin—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00935	0.0153	CbGbCtD
Tretinoin—CYP3A7—Carbamazepine—epilepsy syndrome	0.00931	0.0152	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00931	0.0152	CbGbCtD
Tretinoin—CYP1A1—Phenobarbital—epilepsy syndrome	0.0093	0.0152	CbGbCtD
Tretinoin—CYP2B6—Carbamazepine—epilepsy syndrome	0.00887	0.0145	CbGbCtD
Tretinoin—CYP3A7—Phenytoin—epilepsy syndrome	0.00835	0.0136	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00835	0.0136	CbGbCtD
Tretinoin—CYP2B6—Primidone—epilepsy syndrome	0.00828	0.0135	CbGbCtD
Tretinoin—CYP2A6—Valproic Acid—epilepsy syndrome	0.00814	0.0133	CbGbCtD
Tretinoin—CYP2B6—Phenytoin—epilepsy syndrome	0.00795	0.013	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00745	0.0121	CbGbCtD
Tretinoin—CYP3A7—Phenobarbital—epilepsy syndrome	0.00745	0.0121	CbGbCtD
Tretinoin—CYP2B6—Propofol—epilepsy syndrome	0.00742	0.0121	CbGbCtD
Tretinoin—CYP3A7—Midazolam—epilepsy syndrome	0.00734	0.012	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00734	0.012	CbGbCtD
Tretinoin—CYP2B6—Phenobarbital—epilepsy syndrome	0.00709	0.0116	CbGbCtD
Tretinoin—CYP3A7—Diazepam—epilepsy syndrome	0.00706	0.0115	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00706	0.0115	CbGbCtD
Tretinoin—CYP2B6—Midazolam—epilepsy syndrome	0.00699	0.0114	CbGbCtD
Tretinoin—CYP3A5—Carbamazepine—epilepsy syndrome	0.00699	0.0114	CbGbCtD
Tretinoin—CYP2C9—Trimethadione—epilepsy syndrome	0.00694	0.0113	CbGbCtD
Tretinoin—CYP2B6—Diazepam—epilepsy syndrome	0.00672	0.011	CbGbCtD
Tretinoin—CYP2C8—Carbamazepine—epilepsy syndrome	0.00672	0.011	CbGbCtD
Tretinoin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00652	0.0106	CbGbCtD
Tretinoin—CYP2C8—Primidone—epilepsy syndrome	0.00627	0.0102	CbGbCtD
Tretinoin—CYP3A5—Phenytoin—epilepsy syndrome	0.00627	0.0102	CbGbCtD
Tretinoin—CYP2C8—Phenytoin—epilepsy syndrome	0.00602	0.00983	CbGbCtD
Tretinoin—CYP2C8—Propofol—epilepsy syndrome	0.00562	0.00917	CbGbCtD
Tretinoin—CYP3A5—Phenobarbital—epilepsy syndrome	0.00558	0.00911	CbGbCtD
Tretinoin—CYP3A5—Midazolam—epilepsy syndrome	0.00551	0.00899	CbGbCtD
Tretinoin—CYP2C8—Phenobarbital—epilepsy syndrome	0.00537	0.00876	CbGbCtD
Tretinoin—CYP2B6—Valproic Acid—epilepsy syndrome	0.0053	0.00865	CbGbCtD
Tretinoin—CYP3A5—Diazepam—epilepsy syndrome	0.00529	0.00864	CbGbCtD
Tretinoin—CYP2C8—Diazepam—epilepsy syndrome	0.00509	0.00831	CbGbCtD
Tretinoin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00469	0.00765	CbGbCtD
Tretinoin—CYP2C9—Primidone—epilepsy syndrome	0.00437	0.00714	CbGbCtD
Tretinoin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00434	0.00708	CbGbCtD
Tretinoin—CYP2C9—Phenytoin—epilepsy syndrome	0.0042	0.00686	CbGbCtD
Tretinoin—CYP3A5—Valproic Acid—epilepsy syndrome	0.00417	0.00681	CbGbCtD
Tretinoin—CYP3A4—Felbamate—epilepsy syndrome	0.00403	0.00658	CbGbCtD
Tretinoin—CYP3A4—Trimethadione—epilepsy syndrome	0.00403	0.00658	CbGbCtD
Tretinoin—CYP2C8—Valproic Acid—epilepsy syndrome	0.00401	0.00655	CbGbCtD
Tretinoin—CYP2C9—Propofol—epilepsy syndrome	0.00392	0.0064	CbGbCtD
Tretinoin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00379	0.00619	CbGbCtD
Tretinoin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00375	0.00611	CbGbCtD
Tretinoin—CYP2C9—Diazepam—epilepsy syndrome	0.00355	0.00579	CbGbCtD
Tretinoin—CYP3A4—Clonazepam—epilepsy syndrome	0.00343	0.0056	CbGbCtD
Tretinoin—CYP3A4—Clobazam—epilepsy syndrome	0.00329	0.00536	CbGbCtD
Tretinoin—CYP2C9—Valproic Acid—epilepsy syndrome	0.0028	0.00457	CbGbCtD
Tretinoin—CYP3A4—Rufinamide—epilepsy syndrome	0.0028	0.00456	CbGbCtD
Tretinoin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00272	0.00445	CbGbCtD
Tretinoin—RXRA—ganglion—epilepsy syndrome	0.0026	0.0506	CbGeAlD
Tretinoin—CYP3A4—Primidone—epilepsy syndrome	0.00254	0.00415	CbGbCtD
Tretinoin—CYP3A4—Phenytoin—epilepsy syndrome	0.00244	0.00399	CbGbCtD
Tretinoin—CYP3A4—Propofol—epilepsy syndrome	0.00228	0.00372	CbGbCtD
Tretinoin—CRABP1—hindbrain—epilepsy syndrome	0.00219	0.0426	CbGeAlD
Tretinoin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00218	0.00355	CbGbCtD
Tretinoin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00218	0.00355	CbGbCtD
Tretinoin—CYP3A4—Midazolam—epilepsy syndrome	0.00215	0.0035	CbGbCtD
Tretinoin—CYP3A4—Diazepam—epilepsy syndrome	0.00206	0.00337	CbGbCtD
Tretinoin—CYP3A4—Zonisamide—epilepsy syndrome	0.00202	0.00329	CbGbCtD
Tretinoin—RARG—tongue—epilepsy syndrome	0.00189	0.0367	CbGeAlD
Tretinoin—ALDH1A1—hindbrain—epilepsy syndrome	0.00165	0.0321	CbGeAlD
Tretinoin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00163	0.00266	CbGbCtD
Tretinoin—CYP3A4—Topiramate—epilepsy syndrome	0.00147	0.0024	CbGbCtD
Tretinoin—CRABP1—brainstem—epilepsy syndrome	0.00126	0.0244	CbGeAlD
Tretinoin—CRABP2—forebrain—epilepsy syndrome	0.0011	0.0213	CbGeAlD
Tretinoin—RXRA—forebrain—epilepsy syndrome	0.00109	0.0212	CbGeAlD
Tretinoin—RXRA—telencephalon—epilepsy syndrome	0.001	0.0195	CbGeAlD
Tretinoin—ALDH1A1—brainstem—epilepsy syndrome	0.000948	0.0184	CbGeAlD
Tretinoin—ALDH1A1—forebrain—epilepsy syndrome	0.000915	0.0178	CbGeAlD
Tretinoin—CRABP1—medulla oblongata—epilepsy syndrome	0.000877	0.017	CbGeAlD
Tretinoin—ALDH1A1—telencephalon—epilepsy syndrome	0.000841	0.0163	CbGeAlD
Tretinoin—RXRB—telencephalon—epilepsy syndrome	0.000829	0.0161	CbGeAlD
Tretinoin—CRABP1—midbrain—epilepsy syndrome	0.000801	0.0156	CbGeAlD
Tretinoin—CRABP2—medulla oblongata—epilepsy syndrome	0.000793	0.0154	CbGeAlD
Tretinoin—CRABP1—spinal cord—epilepsy syndrome	0.000782	0.0152	CbGeAlD
Tretinoin—ALDH1A2—head—epilepsy syndrome	0.00072	0.014	CbGeAlD
Tretinoin—CRABP2—spinal cord—epilepsy syndrome	0.000707	0.0137	CbGeAlD
Tretinoin—CRABP1—head—epilepsy syndrome	0.000695	0.0135	CbGeAlD
Tretinoin—RXRG—medulla oblongata—epilepsy syndrome	0.000693	0.0135	CbGeAlD
Tretinoin—RARA—telencephalon—epilepsy syndrome	0.000692	0.0135	CbGeAlD
Tretinoin—ALDH1A2—nervous system—epilepsy syndrome	0.000683	0.0133	CbGeAlD
Tretinoin—RARRES1—brain—epilepsy syndrome	0.00068	0.0132	CbGeAlD
Tretinoin—ALDH1A1—medulla oblongata—epilepsy syndrome	0.000661	0.0128	CbGeAlD
Tretinoin—CRABP1—nervous system—epilepsy syndrome	0.000659	0.0128	CbGeAlD
Tretinoin—ALDH1A2—central nervous system—epilepsy syndrome	0.000657	0.0128	CbGeAlD
Tretinoin—ALDH1A2—cerebellum—epilepsy syndrome	0.000643	0.0125	CbGeAlD
Tretinoin—CRABP1—central nervous system—epilepsy syndrome	0.000634	0.0123	CbGeAlD
Tretinoin—RXRG—midbrain—epilepsy syndrome	0.000633	0.0123	CbGeAlD
Tretinoin—CRABP2—head—epilepsy syndrome	0.000628	0.0122	CbGeAlD
Tretinoin—RXRA—head—epilepsy syndrome	0.000626	0.0122	CbGeAlD
Tretinoin—CRABP1—cerebellum—epilepsy syndrome	0.00062	0.012	CbGeAlD
Tretinoin—RXRG—spinal cord—epilepsy syndrome	0.000618	0.012	CbGeAlD
Tretinoin—ALDH1A1—midbrain—epilepsy syndrome	0.000604	0.0117	CbGeAlD
Tretinoin—CRABP2—nervous system—epilepsy syndrome	0.000596	0.0116	CbGeAlD
Tretinoin—RXRA—nervous system—epilepsy syndrome	0.000593	0.0115	CbGeAlD
Tretinoin—ALDH1A1—spinal cord—epilepsy syndrome	0.000589	0.0114	CbGeAlD
Tretinoin—NR0B1—brain—epilepsy syndrome	0.000586	0.0114	CbGeAlD
Tretinoin—CRABP2—central nervous system—epilepsy syndrome	0.000574	0.0111	CbGeAlD
Tretinoin—RXRA—central nervous system—epilepsy syndrome	0.000571	0.0111	CbGeAlD
Tretinoin—RARB—head—epilepsy syndrome	0.000562	0.0109	CbGeAlD
Tretinoin—CRABP2—cerebellum—epilepsy syndrome	0.000561	0.0109	CbGeAlD
Tretinoin—RXRG—head—epilepsy syndrome	0.000549	0.0107	CbGeAlD
Tretinoin—ALDH1A1—head—epilepsy syndrome	0.000524	0.0102	CbGeAlD
Tretinoin—ALDH1A2—brain—epilepsy syndrome	0.000522	0.0101	CbGeAlD
Tretinoin—RXRG—nervous system—epilepsy syndrome	0.000521	0.0101	CbGeAlD
Tretinoin—RXRB—head—epilepsy syndrome	0.000516	0.01	CbGeAlD
Tretinoin—CRABP1—brain—epilepsy syndrome	0.000504	0.00979	CbGeAlD
Tretinoin—RARB—cerebellum—epilepsy syndrome	0.000501	0.00974	CbGeAlD
Tretinoin—RXRG—central nervous system—epilepsy syndrome	0.000501	0.00974	CbGeAlD
Tretinoin—ALDH1A1—nervous system—epilepsy syndrome	0.000496	0.00965	CbGeAlD
Tretinoin—RXRB—nervous system—epilepsy syndrome	0.00049	0.00951	CbGeAlD
Tretinoin—ALDH1A1—central nervous system—epilepsy syndrome	0.000478	0.00929	CbGeAlD
Tretinoin—RXRB—central nervous system—epilepsy syndrome	0.000471	0.00916	CbGeAlD
Tretinoin—ALDH1A1—cerebellum—epilepsy syndrome	0.000467	0.00908	CbGeAlD
Tretinoin—RXRB—cerebellum—epilepsy syndrome	0.000461	0.00895	CbGeAlD
Tretinoin—RARG—head—epilepsy syndrome	0.000458	0.00891	CbGeAlD
Tretinoin—CRABP2—brain—epilepsy syndrome	0.000455	0.00885	CbGeAlD
Tretinoin—RXRA—brain—epilepsy syndrome	0.000453	0.00881	CbGeAlD
Tretinoin—RARG—nervous system—epilepsy syndrome	0.000435	0.00845	CbGeAlD
Tretinoin—RARA—head—epilepsy syndrome	0.000431	0.00838	CbGeAlD
Tretinoin—RARG—central nervous system—epilepsy syndrome	0.000418	0.00813	CbGeAlD
Tretinoin—RARG—cerebellum—epilepsy syndrome	0.000409	0.00795	CbGeAlD
Tretinoin—RARA—nervous system—epilepsy syndrome	0.000409	0.00794	CbGeAlD
Tretinoin—RARB—brain—epilepsy syndrome	0.000407	0.00791	CbGeAlD
Tretinoin—RXRG—brain—epilepsy syndrome	0.000398	0.00774	CbGeAlD
Tretinoin—RARA—central nervous system—epilepsy syndrome	0.000393	0.00765	CbGeAlD
Tretinoin—RARA—cerebellum—epilepsy syndrome	0.000385	0.00747	CbGeAlD
Tretinoin—ALDH1A1—brain—epilepsy syndrome	0.000379	0.00737	CbGeAlD
Tretinoin—RXRB—brain—epilepsy syndrome	0.000374	0.00727	CbGeAlD
Tretinoin—RARG—brain—epilepsy syndrome	0.000332	0.00646	CbGeAlD
Tretinoin—RARA—brain—epilepsy syndrome	0.000312	0.00607	CbGeAlD
Tretinoin—CYP2A6—cerebellum—epilepsy syndrome	0.000271	0.00527	CbGeAlD
Tretinoin—CYP2A6—brain—epilepsy syndrome	0.00022	0.00428	CbGeAlD
Tretinoin—CYP1A1—head—epilepsy syndrome	0.000158	0.00306	CbGeAlD
Tretinoin—CYP2B6—head—epilepsy syndrome	0.000153	0.00298	CbGeAlD
Tretinoin—CYP1A1—nervous system—epilepsy syndrome	0.000149	0.0029	CbGeAlD
Tretinoin—CYP2B6—nervous system—epilepsy syndrome	0.000145	0.00282	CbGeAlD
Tretinoin—CYP1A1—central nervous system—epilepsy syndrome	0.000144	0.0028	CbGeAlD
Tretinoin—CYP2B6—central nervous system—epilepsy syndrome	0.00014	0.00272	CbGeAlD
Tretinoin—CYP2C8—brain—epilepsy syndrome	0.000124	0.0024	CbGeAlD
Tretinoin—CYP1A1—brain—epilepsy syndrome	0.000114	0.00222	CbGeAlD
Tretinoin—CYP2B6—brain—epilepsy syndrome	0.000111	0.00216	CbGeAlD
Tretinoin—CYP3A4—nervous system—epilepsy syndrome	0.00011	0.00213	CbGeAlD
Tretinoin—CYP3A4—central nervous system—epilepsy syndrome	0.000106	0.00205	CbGeAlD
Tretinoin—Acitretin—ALB—epilepsy syndrome	5.87e-05	0.522	CrCbGaD
Tretinoin—Alitretinoin—ABCB1—epilepsy syndrome	5.37e-05	0.478	CrCbGaD
Tretinoin—Chest pain—Pregabalin—epilepsy syndrome	2.62e-05	0.000116	CcSEcCtD
Tretinoin—Myalgia—Pregabalin—epilepsy syndrome	2.62e-05	0.000116	CcSEcCtD
Tretinoin—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.61e-05	0.000116	CcSEcCtD
Tretinoin—Dizziness—Zonisamide—epilepsy syndrome	2.61e-05	0.000116	CcSEcCtD
Tretinoin—Headache—Diazepam—epilepsy syndrome	2.61e-05	0.000116	CcSEcCtD
Tretinoin—Anxiety—Pregabalin—epilepsy syndrome	2.61e-05	0.000115	CcSEcCtD
Tretinoin—Diarrhoea—Clonazepam—epilepsy syndrome	2.61e-05	0.000115	CcSEcCtD
Tretinoin—Anaemia—Gabapentin—epilepsy syndrome	2.6e-05	0.000115	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.6e-05	0.000115	CcSEcCtD
Tretinoin—Hypotension—Valproic Acid—epilepsy syndrome	2.59e-05	0.000115	CcSEcCtD
Tretinoin—Asthenia—Carbamazepine—epilepsy syndrome	2.59e-05	0.000115	CcSEcCtD
Tretinoin—Agitation—Gabapentin—epilepsy syndrome	2.59e-05	0.000115	CcSEcCtD
Tretinoin—Diarrhoea—Phenytoin—epilepsy syndrome	2.59e-05	0.000115	CcSEcCtD
Tretinoin—Discomfort—Pregabalin—epilepsy syndrome	2.58e-05	0.000114	CcSEcCtD
Tretinoin—Nausea—Fosphenytoin—epilepsy syndrome	2.58e-05	0.000114	CcSEcCtD
Tretinoin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000114	CcSEcCtD
Tretinoin—Erythema multiforme—Topiramate—epilepsy syndrome	2.57e-05	0.000114	CcSEcCtD
Tretinoin—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.57e-05	0.000114	CcSEcCtD
Tretinoin—Vomiting—Felbamate—epilepsy syndrome	2.57e-05	0.000114	CcSEcCtD
Tretinoin—Dry mouth—Pregabalin—epilepsy syndrome	2.56e-05	0.000113	CcSEcCtD
Tretinoin—Pruritus—Carbamazepine—epilepsy syndrome	2.56e-05	0.000113	CcSEcCtD
Tretinoin—Rash—Felbamate—epilepsy syndrome	2.55e-05	0.000113	CcSEcCtD
Tretinoin—Eye disorder—Topiramate—epilepsy syndrome	2.54e-05	0.000113	CcSEcCtD
Tretinoin—Dermatitis—Felbamate—epilepsy syndrome	2.54e-05	0.000113	CcSEcCtD
Tretinoin—Malaise—Gabapentin—epilepsy syndrome	2.54e-05	0.000112	CcSEcCtD
Tretinoin—Tinnitus—Topiramate—epilepsy syndrome	2.54e-05	0.000112	CcSEcCtD
Tretinoin—Headache—Felbamate—epilepsy syndrome	2.53e-05	0.000112	CcSEcCtD
Tretinoin—Confusional state—Pregabalin—epilepsy syndrome	2.53e-05	0.000112	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.53e-05	0.000112	CcSEcCtD
Tretinoin—Flushing—Topiramate—epilepsy syndrome	2.53e-05	0.000112	CcSEcCtD
Tretinoin—Syncope—Gabapentin—epilepsy syndrome	2.53e-05	0.000112	CcSEcCtD
Tretinoin—Dizziness—Clonazepam—epilepsy syndrome	2.52e-05	0.000111	CcSEcCtD
Tretinoin—Nausea—Vigabatrin—epilepsy syndrome	2.52e-05	0.000111	CcSEcCtD
Tretinoin—Vomiting—Zonisamide—epilepsy syndrome	2.51e-05	0.000111	CcSEcCtD
Tretinoin—Insomnia—Valproic Acid—epilepsy syndrome	2.51e-05	0.000111	CcSEcCtD
Tretinoin—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.51e-05	0.000111	CcSEcCtD
Tretinoin—Oedema—Pregabalin—epilepsy syndrome	2.51e-05	0.000111	CcSEcCtD
Tretinoin—Asthenia—Lamotrigine—epilepsy syndrome	2.5e-05	0.000111	CcSEcCtD
Tretinoin—Dizziness—Phenytoin—epilepsy syndrome	2.5e-05	0.000111	CcSEcCtD
Tretinoin—Rash—Zonisamide—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Infection—Pregabalin—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Palpitations—Gabapentin—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Dermatitis—Zonisamide—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.49e-05	0.00011	CcSEcCtD
Tretinoin—Nausea—Diazepam—epilepsy syndrome	2.48e-05	0.00011	CcSEcCtD
Tretinoin—Loss of consciousness—Gabapentin—epilepsy syndrome	2.48e-05	0.00011	CcSEcCtD
Tretinoin—Headache—Zonisamide—epilepsy syndrome	2.48e-05	0.00011	CcSEcCtD
Tretinoin—Dyspnoea—Valproic Acid—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Angiopathy—Topiramate—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Pruritus—Lamotrigine—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Shock—Pregabalin—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Somnolence—Valproic Acid—epilepsy syndrome	2.47e-05	0.000109	CcSEcCtD
Tretinoin—Nervous system disorder—Pregabalin—epilepsy syndrome	2.46e-05	0.000109	CcSEcCtD
Tretinoin—Cough—Gabapentin—epilepsy syndrome	2.46e-05	0.000109	CcSEcCtD
Tretinoin—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.46e-05	0.000109	CcSEcCtD
Tretinoin—Tachycardia—Pregabalin—epilepsy syndrome	2.45e-05	0.000108	CcSEcCtD
Tretinoin—Chills—Topiramate—epilepsy syndrome	2.44e-05	0.000108	CcSEcCtD
Tretinoin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.44e-05	0.000108	CcSEcCtD
Tretinoin—Convulsion—Gabapentin—epilepsy syndrome	2.44e-05	0.000108	CcSEcCtD
Tretinoin—Skin disorder—Pregabalin—epilepsy syndrome	2.44e-05	0.000108	CcSEcCtD
Tretinoin—Hypertension—Gabapentin—epilepsy syndrome	2.43e-05	0.000108	CcSEcCtD
Tretinoin—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.42e-05	0.000107	CcSEcCtD
Tretinoin—Vomiting—Clonazepam—epilepsy syndrome	2.42e-05	0.000107	CcSEcCtD
Tretinoin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.41e-05	0.000107	CcSEcCtD
Tretinoin—Alopecia—Topiramate—epilepsy syndrome	2.41e-05	0.000106	CcSEcCtD
Tretinoin—Vomiting—Phenytoin—epilepsy syndrome	2.41e-05	0.000106	CcSEcCtD
Tretinoin—Rash—Clonazepam—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Dermatitis—Clonazepam—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Chest pain—Gabapentin—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Arthralgia—Gabapentin—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Myalgia—Gabapentin—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Nausea—Felbamate—epilepsy syndrome	2.4e-05	0.000106	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Fatigue—Valproic Acid—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Anxiety—Gabapentin—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Anorexia—Pregabalin—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Dizziness—Carbamazepine—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Headache—Clonazepam—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Rash—Phenytoin—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Mental disorder—Topiramate—epilepsy syndrome	2.39e-05	0.000106	CcSEcCtD
Tretinoin—Dermatitis—Phenytoin—epilepsy syndrome	2.38e-05	0.000105	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.38e-05	0.000105	CcSEcCtD
Tretinoin—Rash—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Pain—Valproic Acid—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Constipation—Valproic Acid—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Headache—Phenytoin—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Malnutrition—Topiramate—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Erythema—Topiramate—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Discomfort—Gabapentin—epilepsy syndrome	2.37e-05	0.000105	CcSEcCtD
Tretinoin—Headache—Oxcarbazepine—epilepsy syndrome	2.36e-05	0.000104	CcSEcCtD
Tretinoin—Nausea—Zonisamide—epilepsy syndrome	2.35e-05	0.000104	CcSEcCtD
Tretinoin—Dry mouth—Gabapentin—epilepsy syndrome	2.35e-05	0.000104	CcSEcCtD
Tretinoin—Hypotension—Pregabalin—epilepsy syndrome	2.34e-05	0.000104	CcSEcCtD
Tretinoin—Flatulence—Topiramate—epilepsy syndrome	2.34e-05	0.000103	CcSEcCtD
Tretinoin—Tension—Topiramate—epilepsy syndrome	2.33e-05	0.000103	CcSEcCtD
Tretinoin—Confusional state—Gabapentin—epilepsy syndrome	2.32e-05	0.000103	CcSEcCtD
Tretinoin—Dizziness—Lamotrigine—epilepsy syndrome	2.31e-05	0.000102	CcSEcCtD
Tretinoin—Nervousness—Topiramate—epilepsy syndrome	2.3e-05	0.000102	CcSEcCtD
Tretinoin—Oedema—Gabapentin—epilepsy syndrome	2.3e-05	0.000102	CcSEcCtD
Tretinoin—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.3e-05	0.000102	CcSEcCtD
Tretinoin—Vomiting—Carbamazepine—epilepsy syndrome	2.3e-05	0.000102	CcSEcCtD
Tretinoin—Back pain—Topiramate—epilepsy syndrome	2.29e-05	0.000101	CcSEcCtD
Tretinoin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.29e-05	0.000101	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.28e-05	0.000101	CcSEcCtD
Tretinoin—Infection—Gabapentin—epilepsy syndrome	2.28e-05	0.000101	CcSEcCtD
Tretinoin—Rash—Carbamazepine—epilepsy syndrome	2.28e-05	0.000101	CcSEcCtD
Tretinoin—Dermatitis—Carbamazepine—epilepsy syndrome	2.28e-05	0.000101	CcSEcCtD
Tretinoin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.27e-05	0.0001	CcSEcCtD
Tretinoin—Insomnia—Pregabalin—epilepsy syndrome	2.27e-05	0.0001	CcSEcCtD
Tretinoin—Nausea—Clonazepam—epilepsy syndrome	2.26e-05	0.0001	CcSEcCtD
Tretinoin—Headache—Carbamazepine—epilepsy syndrome	2.26e-05	0.0001	CcSEcCtD
Tretinoin—Shock—Gabapentin—epilepsy syndrome	2.26e-05	0.0001	CcSEcCtD
Tretinoin—Nervous system disorder—Gabapentin—epilepsy syndrome	2.26e-05	9.98e-05	CcSEcCtD
Tretinoin—Paraesthesia—Pregabalin—epilepsy syndrome	2.25e-05	9.96e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.25e-05	9.96e-05	CcSEcCtD
Tretinoin—Nausea—Phenytoin—epilepsy syndrome	2.25e-05	9.94e-05	CcSEcCtD
Tretinoin—Tachycardia—Gabapentin—epilepsy syndrome	2.24e-05	9.93e-05	CcSEcCtD
Tretinoin—Dyspnoea—Pregabalin—epilepsy syndrome	2.24e-05	9.89e-05	CcSEcCtD
Tretinoin—Nausea—Oxcarbazepine—epilepsy syndrome	2.24e-05	9.89e-05	CcSEcCtD
Tretinoin—Vision blurred—Topiramate—epilepsy syndrome	2.23e-05	9.88e-05	CcSEcCtD
Tretinoin—Skin disorder—Gabapentin—epilepsy syndrome	2.23e-05	9.88e-05	CcSEcCtD
Tretinoin—Somnolence—Pregabalin—epilepsy syndrome	2.23e-05	9.86e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.22e-05	9.83e-05	CcSEcCtD
Tretinoin—Tremor—Topiramate—epilepsy syndrome	2.22e-05	9.82e-05	CcSEcCtD
Tretinoin—Vomiting—Lamotrigine—epilepsy syndrome	2.22e-05	9.82e-05	CcSEcCtD
Tretinoin—Urticaria—Valproic Acid—epilepsy syndrome	2.2e-05	9.75e-05	CcSEcCtD
Tretinoin—Rash—Lamotrigine—epilepsy syndrome	2.2e-05	9.74e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.2e-05	9.73e-05	CcSEcCtD
Tretinoin—Dermatitis—Lamotrigine—epilepsy syndrome	2.2e-05	9.73e-05	CcSEcCtD
Tretinoin—Body temperature increased—Valproic Acid—epilepsy syndrome	2.19e-05	9.7e-05	CcSEcCtD
Tretinoin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.19e-05	9.7e-05	CcSEcCtD
Tretinoin—Anorexia—Gabapentin—epilepsy syndrome	2.19e-05	9.7e-05	CcSEcCtD
Tretinoin—Anaemia—Topiramate—epilepsy syndrome	2.19e-05	9.69e-05	CcSEcCtD
Tretinoin—Headache—Lamotrigine—epilepsy syndrome	2.19e-05	9.67e-05	CcSEcCtD
Tretinoin—Decreased appetite—Pregabalin—epilepsy syndrome	2.18e-05	9.64e-05	CcSEcCtD
Tretinoin—Agitation—Topiramate—epilepsy syndrome	2.18e-05	9.64e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.17e-05	9.58e-05	CcSEcCtD
Tretinoin—Fatigue—Pregabalin—epilepsy syndrome	2.16e-05	9.56e-05	CcSEcCtD
Tretinoin—Hypotension—Gabapentin—epilepsy syndrome	2.15e-05	9.51e-05	CcSEcCtD
Tretinoin—Nausea—Carbamazepine—epilepsy syndrome	2.15e-05	9.49e-05	CcSEcCtD
Tretinoin—Pain—Pregabalin—epilepsy syndrome	2.14e-05	9.49e-05	CcSEcCtD
Tretinoin—Constipation—Pregabalin—epilepsy syndrome	2.14e-05	9.49e-05	CcSEcCtD
Tretinoin—Malaise—Topiramate—epilepsy syndrome	2.14e-05	9.46e-05	CcSEcCtD
Tretinoin—Syncope—Topiramate—epilepsy syndrome	2.13e-05	9.4e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.1e-05	9.27e-05	CcSEcCtD
Tretinoin—Palpitations—Topiramate—epilepsy syndrome	2.09e-05	9.27e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Topiramate—epilepsy syndrome	2.08e-05	9.22e-05	CcSEcCtD
Tretinoin—Insomnia—Gabapentin—epilepsy syndrome	2.08e-05	9.2e-05	CcSEcCtD
Tretinoin—Nausea—Lamotrigine—epilepsy syndrome	2.07e-05	9.17e-05	CcSEcCtD
Tretinoin—Cough—Topiramate—epilepsy syndrome	2.07e-05	9.15e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.07e-05	9.14e-05	CcSEcCtD
Tretinoin—Paraesthesia—Gabapentin—epilepsy syndrome	2.06e-05	9.13e-05	CcSEcCtD
Tretinoin—Convulsion—Topiramate—epilepsy syndrome	2.05e-05	9.09e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.05e-05	9.07e-05	CcSEcCtD
Tretinoin—Dyspnoea—Gabapentin—epilepsy syndrome	2.05e-05	9.07e-05	CcSEcCtD
Tretinoin—Hypertension—Topiramate—epilepsy syndrome	2.05e-05	9.05e-05	CcSEcCtD
Tretinoin—Somnolence—Gabapentin—epilepsy syndrome	2.04e-05	9.04e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.04e-05	9.04e-05	CcSEcCtD
Tretinoin—Dyspepsia—Gabapentin—epilepsy syndrome	2.02e-05	8.95e-05	CcSEcCtD
Tretinoin—Chest pain—Topiramate—epilepsy syndrome	2.02e-05	8.93e-05	CcSEcCtD
Tretinoin—Myalgia—Topiramate—epilepsy syndrome	2.02e-05	8.93e-05	CcSEcCtD
Tretinoin—Arthralgia—Topiramate—epilepsy syndrome	2.02e-05	8.93e-05	CcSEcCtD
Tretinoin—Anxiety—Topiramate—epilepsy syndrome	2.01e-05	8.9e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2e-05	8.87e-05	CcSEcCtD
Tretinoin—Decreased appetite—Gabapentin—epilepsy syndrome	2e-05	8.84e-05	CcSEcCtD
Tretinoin—Discomfort—Topiramate—epilepsy syndrome	1.99e-05	8.82e-05	CcSEcCtD
Tretinoin—Urticaria—Pregabalin—epilepsy syndrome	1.99e-05	8.81e-05	CcSEcCtD
Tretinoin—Asthenia—Valproic Acid—epilepsy syndrome	1.99e-05	8.8e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.99e-05	8.78e-05	CcSEcCtD
Tretinoin—Fatigue—Gabapentin—epilepsy syndrome	1.98e-05	8.77e-05	CcSEcCtD
Tretinoin—Body temperature increased—Pregabalin—epilepsy syndrome	1.98e-05	8.77e-05	CcSEcCtD
Tretinoin—Abdominal pain—Pregabalin—epilepsy syndrome	1.98e-05	8.77e-05	CcSEcCtD
Tretinoin—Dry mouth—Topiramate—epilepsy syndrome	1.97e-05	8.73e-05	CcSEcCtD
Tretinoin—Pain—Gabapentin—epilepsy syndrome	1.97e-05	8.7e-05	CcSEcCtD
Tretinoin—Constipation—Gabapentin—epilepsy syndrome	1.97e-05	8.7e-05	CcSEcCtD
Tretinoin—Pruritus—Valproic Acid—epilepsy syndrome	1.96e-05	8.68e-05	CcSEcCtD
Tretinoin—Confusional state—Topiramate—epilepsy syndrome	1.95e-05	8.63e-05	CcSEcCtD
Tretinoin—Oedema—Topiramate—epilepsy syndrome	1.93e-05	8.56e-05	CcSEcCtD
Tretinoin—Infection—Topiramate—epilepsy syndrome	1.92e-05	8.5e-05	CcSEcCtD
Tretinoin—Shock—Topiramate—epilepsy syndrome	1.9e-05	8.42e-05	CcSEcCtD
Tretinoin—Diarrhoea—Valproic Acid—epilepsy syndrome	1.9e-05	8.4e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Topiramate—epilepsy syndrome	1.9e-05	8.39e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Gabapentin—epilepsy syndrome	1.9e-05	8.38e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Topiramate—epilepsy syndrome	1.89e-05	8.38e-05	CcSEcCtD
Tretinoin—Tachycardia—Topiramate—epilepsy syndrome	1.89e-05	8.35e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.88e-05	8.32e-05	CcSEcCtD
Tretinoin—Skin disorder—Topiramate—epilepsy syndrome	1.88e-05	8.31e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Topiramate—epilepsy syndrome	1.87e-05	8.27e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.85e-05	8.17e-05	CcSEcCtD
Tretinoin—Anorexia—Topiramate—epilepsy syndrome	1.84e-05	8.16e-05	CcSEcCtD
Tretinoin—Dizziness—Valproic Acid—epilepsy syndrome	1.83e-05	8.11e-05	CcSEcCtD
Tretinoin—Urticaria—Gabapentin—epilepsy syndrome	1.83e-05	8.08e-05	CcSEcCtD
Tretinoin—Abdominal pain—Gabapentin—epilepsy syndrome	1.82e-05	8.04e-05	CcSEcCtD
Tretinoin—Body temperature increased—Gabapentin—epilepsy syndrome	1.82e-05	8.04e-05	CcSEcCtD
Tretinoin—Hypotension—Topiramate—epilepsy syndrome	1.81e-05	8e-05	CcSEcCtD
Tretinoin—Asthenia—Pregabalin—epilepsy syndrome	1.8e-05	7.96e-05	CcSEcCtD
Tretinoin—Pruritus—Pregabalin—epilepsy syndrome	1.77e-05	7.85e-05	CcSEcCtD
Tretinoin—Vomiting—Valproic Acid—epilepsy syndrome	1.76e-05	7.8e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.76e-05	7.8e-05	CcSEcCtD
Tretinoin—Insomnia—Topiramate—epilepsy syndrome	1.75e-05	7.74e-05	CcSEcCtD
Tretinoin—Rash—Valproic Acid—epilepsy syndrome	1.75e-05	7.74e-05	CcSEcCtD
Tretinoin—Dermatitis—Valproic Acid—epilepsy syndrome	1.75e-05	7.73e-05	CcSEcCtD
Tretinoin—Headache—Valproic Acid—epilepsy syndrome	1.74e-05	7.69e-05	CcSEcCtD
Tretinoin—Paraesthesia—Topiramate—epilepsy syndrome	1.74e-05	7.68e-05	CcSEcCtD
Tretinoin—Dyspnoea—Topiramate—epilepsy syndrome	1.72e-05	7.63e-05	CcSEcCtD
Tretinoin—Somnolence—Topiramate—epilepsy syndrome	1.72e-05	7.61e-05	CcSEcCtD
Tretinoin—Diarrhoea—Pregabalin—epilepsy syndrome	1.72e-05	7.59e-05	CcSEcCtD
Tretinoin—Dyspepsia—Topiramate—epilepsy syndrome	1.7e-05	7.53e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Gabapentin—epilepsy syndrome	1.69e-05	7.49e-05	CcSEcCtD
Tretinoin—Decreased appetite—Topiramate—epilepsy syndrome	1.68e-05	7.44e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.67e-05	7.39e-05	CcSEcCtD
Tretinoin—Fatigue—Topiramate—epilepsy syndrome	1.67e-05	7.38e-05	CcSEcCtD
Tretinoin—Dizziness—Pregabalin—epilepsy syndrome	1.66e-05	7.34e-05	CcSEcCtD
Tretinoin—Pain—Topiramate—epilepsy syndrome	1.65e-05	7.32e-05	CcSEcCtD
Tretinoin—Constipation—Topiramate—epilepsy syndrome	1.65e-05	7.32e-05	CcSEcCtD
Tretinoin—Asthenia—Gabapentin—epilepsy syndrome	1.65e-05	7.3e-05	CcSEcCtD
Tretinoin—Nausea—Valproic Acid—epilepsy syndrome	1.65e-05	7.29e-05	CcSEcCtD
Tretinoin—Pruritus—Gabapentin—epilepsy syndrome	1.63e-05	7.2e-05	CcSEcCtD
Tretinoin—Vomiting—Pregabalin—epilepsy syndrome	1.59e-05	7.05e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Topiramate—epilepsy syndrome	1.59e-05	7.05e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.58e-05	7e-05	CcSEcCtD
Tretinoin—Rash—Pregabalin—epilepsy syndrome	1.58e-05	6.99e-05	CcSEcCtD
Tretinoin—Dermatitis—Pregabalin—epilepsy syndrome	1.58e-05	6.99e-05	CcSEcCtD
Tretinoin—Diarrhoea—Gabapentin—epilepsy syndrome	1.57e-05	6.96e-05	CcSEcCtD
Tretinoin—Headache—Pregabalin—epilepsy syndrome	1.57e-05	6.95e-05	CcSEcCtD
Tretinoin—Urticaria—Topiramate—epilepsy syndrome	1.54e-05	6.8e-05	CcSEcCtD
Tretinoin—Body temperature increased—Topiramate—epilepsy syndrome	1.53e-05	6.77e-05	CcSEcCtD
Tretinoin—Abdominal pain—Topiramate—epilepsy syndrome	1.53e-05	6.77e-05	CcSEcCtD
Tretinoin—Dizziness—Gabapentin—epilepsy syndrome	1.52e-05	6.73e-05	CcSEcCtD
Tretinoin—Nausea—Pregabalin—epilepsy syndrome	1.49e-05	6.59e-05	CcSEcCtD
Tretinoin—Vomiting—Gabapentin—epilepsy syndrome	1.46e-05	6.47e-05	CcSEcCtD
Tretinoin—Rash—Gabapentin—epilepsy syndrome	1.45e-05	6.41e-05	CcSEcCtD
Tretinoin—Dermatitis—Gabapentin—epilepsy syndrome	1.45e-05	6.41e-05	CcSEcCtD
Tretinoin—Headache—Gabapentin—epilepsy syndrome	1.44e-05	6.37e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Topiramate—epilepsy syndrome	1.43e-05	6.31e-05	CcSEcCtD
Tretinoin—Asthenia—Topiramate—epilepsy syndrome	1.39e-05	6.14e-05	CcSEcCtD
Tretinoin—Pruritus—Topiramate—epilepsy syndrome	1.37e-05	6.05e-05	CcSEcCtD
Tretinoin—Nausea—Gabapentin—epilepsy syndrome	1.37e-05	6.04e-05	CcSEcCtD
Tretinoin—Diarrhoea—Topiramate—epilepsy syndrome	1.32e-05	5.86e-05	CcSEcCtD
Tretinoin—Dizziness—Topiramate—epilepsy syndrome	1.28e-05	5.66e-05	CcSEcCtD
Tretinoin—Vomiting—Topiramate—epilepsy syndrome	1.23e-05	5.44e-05	CcSEcCtD
Tretinoin—Rash—Topiramate—epilepsy syndrome	1.22e-05	5.4e-05	CcSEcCtD
Tretinoin—Dermatitis—Topiramate—epilepsy syndrome	1.22e-05	5.39e-05	CcSEcCtD
Tretinoin—Headache—Topiramate—epilepsy syndrome	1.21e-05	5.36e-05	CcSEcCtD
Tretinoin—Nausea—Topiramate—epilepsy syndrome	1.15e-05	5.08e-05	CcSEcCtD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.47e-06	4.08e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	4.46e-06	4.07e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—HMOX1—epilepsy syndrome	4.46e-06	4.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.46e-06	4.07e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	4.46e-06	4.07e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	4.46e-06	4.07e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CAT—epilepsy syndrome	4.4e-06	4.02e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AGT—epilepsy syndrome	4.4e-06	4.02e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	4.4e-06	4.01e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	4.39e-06	4.01e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GPX1—epilepsy syndrome	4.39e-06	4e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALAD—epilepsy syndrome	4.34e-06	3.97e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NT5E—epilepsy syndrome	4.34e-06	3.97e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—APOE—epilepsy syndrome	4.31e-06	3.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ABCB1—epilepsy syndrome	4.28e-06	3.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AQP1—epilepsy syndrome	4.27e-06	3.89e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.24e-06	3.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.24e-06	3.87e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.23e-06	3.86e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	4.21e-06	3.84e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	4.21e-06	3.84e-05	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—AKT1—epilepsy syndrome	4.19e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	4.18e-06	3.82e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—BCHE—epilepsy syndrome	4.16e-06	3.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	4.14e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	4.14e-06	3.78e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.1e-06	3.74e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	4.06e-06	3.7e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	4.03e-06	3.67e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.99e-06	3.64e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GPX1—epilepsy syndrome	3.98e-06	3.63e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—epilepsy syndrome	3.98e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.97e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	3.97e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	3.93e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.92e-06	3.58e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TH—epilepsy syndrome	3.91e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.9e-06	3.56e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—epilepsy syndrome	3.89e-06	3.55e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—epilepsy syndrome	3.89e-06	3.55e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—epilepsy syndrome	3.89e-06	3.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	3.86e-06	3.52e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	3.86e-06	3.52e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AGT—epilepsy syndrome	3.85e-06	3.51e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.84e-06	3.51e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	3.83e-06	3.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.82e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—BCHE—epilepsy syndrome	3.82e-06	3.48e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.78e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.78e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.78e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.78e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.78e-06	3.45e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—APOE—epilepsy syndrome	3.77e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	3.72e-06	3.39e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—POMC—epilepsy syndrome	3.7e-06	3.38e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	3.64e-06	3.32e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.63e-06	3.32e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	3.62e-06	3.31e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	3.6e-06	3.29e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	3.6e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.59e-06	3.28e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TH—epilepsy syndrome	3.59e-06	3.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.58e-06	3.27e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.54e-06	3.23e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.52e-06	3.21e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.52e-06	3.21e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AGT—epilepsy syndrome	3.49e-06	3.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.47e-06	3.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.46e-06	3.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.46e-06	3.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.46e-06	3.16e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	3.43e-06	3.13e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—APOE—epilepsy syndrome	3.42e-06	3.12e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—epilepsy syndrome	3.38e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—epilepsy syndrome	3.38e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	3.34e-06	3.05e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.34e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.33e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	3.32e-06	3.03e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.3e-06	3.01e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	3.27e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	3.25e-06	2.96e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—POMC—epilepsy syndrome	3.24e-06	2.95e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CAT—epilepsy syndrome	3.22e-06	2.94e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.21e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.21e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3.17e-06	2.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	3.15e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.14e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.14e-06	2.87e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	3.14e-06	2.86e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	3.09e-06	2.82e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—epilepsy syndrome	3.09e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—BCHE—epilepsy syndrome	3.08e-06	2.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	3.07e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	3.05e-06	2.78e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—epilepsy syndrome	3.03e-06	2.77e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.02e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.02e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	3.02e-06	2.76e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—BCHE—epilepsy syndrome	3.01e-06	2.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.01e-06	2.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	3e-06	2.74e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	2.99e-06	2.73e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—epilepsy syndrome	2.96e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAT—epilepsy syndrome	2.95e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—epilepsy syndrome	2.95e-06	2.7e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—epilepsy syndrome	2.95e-06	2.69e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.94e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.94e-06	2.68e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—POMC—epilepsy syndrome	2.94e-06	2.68e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.92e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.92e-06	2.66e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.91e-06	2.65e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—epilepsy syndrome	2.91e-06	2.65e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—epilepsy syndrome	2.91e-06	2.65e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TH—epilepsy syndrome	2.89e-06	2.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	2.87e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.87e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.87e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.87e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.87e-06	2.62e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.86e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.84e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.84e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TH—epilepsy syndrome	2.83e-06	2.58e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.76e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.75e-06	2.51e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.73e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.73e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.71e-06	2.48e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.68e-06	2.45e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—epilepsy syndrome	2.68e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.67e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TH—epilepsy syndrome	2.67e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPX1—epilepsy syndrome	2.67e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.63e-06	2.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.62e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.62e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.61e-06	2.38e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	2.58e-06	2.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.57e-06	2.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.56e-06	2.34e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.56e-06	2.33e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.52e-06	2.3e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.5e-06	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.5e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.49e-06	2.27e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.48e-06	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.46e-06	2.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.46e-06	2.25e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TH—epilepsy syndrome	2.45e-06	2.24e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2.42e-06	2.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.41e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAT—epilepsy syndrome	2.38e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.36e-06	2.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.36e-06	2.15e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AGT—epilepsy syndrome	2.34e-06	2.14e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	2.14e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.33e-06	2.13e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	2.32e-06	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—epilepsy syndrome	2.3e-06	2.1e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.29e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.27e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.24e-06	2.05e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.24e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	2.23e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAT—epilepsy syndrome	2.2e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—epilepsy syndrome	2.16e-06	1.97e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.15e-06	1.96e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	2.14e-06	1.95e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.13e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.12e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.11e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.07e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.07e-06	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.05e-06	1.87e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.02e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.02e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TH—epilepsy syndrome	1.99e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.99e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.97e-06	1.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.96e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.96e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.96e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.89e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.85e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.85e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.83e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.81e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.8e-06	1.64e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.75e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.71e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.69e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.66e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.65e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.64e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.64e-06	1.49e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.6e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.6e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.59e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.57e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.57e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.56e-06	1.42e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—epilepsy syndrome	1.51e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.49e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—epilepsy syndrome	1.48e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.48e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.47e-06	1.34e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.45e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.42e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.41e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.4e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.35e-06	1.23e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.34e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.33e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.32e-06	1.21e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.32e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.3e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—epilepsy syndrome	1.3e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.28e-06	1.16e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.27e-06	1.16e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.24e-06	1.13e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.23e-06	1.12e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—epilepsy syndrome	1.18e-06	1.07e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	1.17e-06	1.07e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.1e-06	1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.1e-06	1e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.08e-06	9.89e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.07e-06	9.81e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.05e-06	9.62e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—epilepsy syndrome	1e-06	9.12e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.8e-07	8.94e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.75e-07	7.98e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—epilepsy syndrome	8.63e-07	7.87e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.59e-07	7.84e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.42e-07	7.68e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—epilepsy syndrome	7.91e-07	7.22e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.23e-07	6.6e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.59e-07	6.02e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—epilepsy syndrome	6.38e-07	5.82e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—epilepsy syndrome	6.23e-07	5.69e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—epilepsy syndrome	5.89e-07	5.38e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.77e-07	5.26e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.4e-07	4.93e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.4e-07	4.01e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.9e-07	2.65e-06	CbGpPWpGaD
